Ocular Therapeutix Statistics
Total Valuation
OCUL has a market cap or net worth of $2.12 billion. The enterprise value is $1.81 billion.
Important Dates
The last earnings date was Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OCUL has 174.00 million shares outstanding. The number of shares has increased by 46.68% in one year.
| Current Share Class | 174.00M |
| Shares Outstanding | 174.00M |
| Shares Change (YoY) | +46.68% |
| Shares Change (QoQ) | +1.89% |
| Owned by Insiders (%) | 0.97% |
| Owned by Institutions (%) | 75.07% |
| Float | 145.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 36.48 |
| Forward PS | 34.16 |
| PB Ratio | 6.90 |
| P/TBV Ratio | 6.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 31.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.09, with a Debt / Equity ratio of 0.25.
| Current Ratio | 10.09 |
| Quick Ratio | 9.83 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.56 |
Financial Efficiency
Return on equity (ROE) is -63.41% and return on invested capital (ROIC) is -36.09%.
| Return on Equity (ROE) | -63.41% |
| Return on Assets (ROA) | -31.14% |
| Return on Invested Capital (ROIC) | -36.09% |
| Return on Capital Employed (ROCE) | -59.07% |
| Revenue Per Employee | $206,803 |
| Profits Per Employee | -$791,051 |
| Employee Count | 274 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 63.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.82% in the last 52 weeks. The beta is 1.49, so OCUL's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | +35.82% |
| 50-Day Moving Average | 11.28 |
| 200-Day Moving Average | 8.85 |
| Relative Strength Index (RSI) | 54.04 |
| Average Volume (20 Days) | 2,075,194 |
Short Selling Information
The latest short interest is 13.08 million, so 7.52% of the outstanding shares have been sold short.
| Short Interest | 13.08M |
| Short Previous Month | 12.83M |
| Short % of Shares Out | 7.52% |
| Short % of Float | 9.01% |
| Short Ratio (days to cover) | 6.29 |
Income Statement
In the last 12 months, OCUL had revenue of $56.66 million and -$216.75 million in losses. Loss per share was -$1.28.
| Revenue | 56.66M |
| Gross Profit | -121.31M |
| Operating Income | -241.23M |
| Pretax Income | -138.36M |
| Net Income | -216.75M |
| EBITDA | -237.32M |
| EBIT | -241.23M |
| Loss Per Share | -$1.28 |
Full Income StatementBalance Sheet
The company has $391.13 million in cash and $76.94 million in debt, giving a net cash position of $314.20 million or $1.81 per share.
| Cash & Cash Equivalents | 391.13M |
| Total Debt | 76.94M |
| Net Cash | 314.20M |
| Net Cash Per Share | $1.81 |
| Equity (Book Value) | 305.92M |
| Book Value Per Share | 1.77 |
| Working Capital | 390.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$175.90 million and capital expenditures -$3.47 million, giving a free cash flow of -$179.37 million.
| Operating Cash Flow | -175.90M |
| Capital Expenditures | -3.47M |
| Free Cash Flow | -179.37M |
| FCF Per Share | -$1.03 |
Full Cash Flow StatementMargins
| Gross Margin | -214.09% |
| Operating Margin | -425.73% |
| Pretax Margin | -382.51% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -46.68% |
| Shareholder Yield | -46.68% |
| Earnings Yield | -10.20% |
| FCF Yield | -8.44% |
Analyst Forecast
The average price target for OCUL is $17.20, which is 40.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.20 |
| Price Target Difference | 40.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 55.38% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OCUL has an Altman Z-Score of 1.67 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.67 |
| Piotroski F-Score | 1 |
